Biotech | August 08, 2021
TAKE divests stake in Navitas Life Sciences to HIG
The transaction is expected to close in the Q4FY22
The transaction is expected to close in the Q4FY22
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
MitraClip implants give a new lease of life for frail and elderly patients who cannot go in for conventional open-heart surgery
AstraZeneca, Sinopharm and Moderna were part of the study
Aditya Puri former MD of HDFC bank joins Solara board as chairman
Arch Pharma Labs has filed the application
Ultreon 1.0 Software, the first-of-its-kind imaging software, merges optical coherence tomography with the power of automation using AI -
The company posted net profit of Rs.19.36 crores for the period ended June 30, 2020.
Drug formulations and biologics make impressive gains
The Phase III clinical trial for NONS is expected to be completed by Q4 2021.
Subscribe To Our Newsletter & Stay Updated
